Skip to main content
Erschienen in: Annals of Surgical Oncology 12/2011

01.11.2011 | Gynecologic Oncology

Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study

verfasst von: Antonino Ditto, MD, Fabio Martinelli, MD, Flavia Mattana, ScD, Claudio Reato, MD, Eugenio Solima, MD, Marialuisa Carcangiu, MD, Edward Haeusler, MD, Luigi Mariani, MD, Francesco Raspagliesi, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

The purpose of this observational study was to evaluate disease-free survival, overall survival, local recurrence rate, and morbidities in patients submitted to class III nerve-sparing radical hysterectomy (NSRH) compared with standard radical hysterectomy (RH) in cervical cancer (CC). This was a comparative study in the context of multimodal therapies.

Materials and Methods

We investigated patients with CC admitted to the National Cancer Institute of Milan between January 4, 2001, and September 29, 2009, treated with NSRH. We compared patients operated with RH between March 20, 1980, and December 28, 1995. A total of 496 patients were enrolled. The median follow-up was 93 months (42 and 159 months for the NSRH and RH groups, respectively).

Results

The overall number of relapses was 30 out of 185 and 60 out of 311 for NSRH and RH, respectively. Five-year disease-free survival estimate was 78.9% (95% confidence interval [CI] 72.0–85.7) in NSRH and 79.8% (95% CI 75.3–84.3) in RH (P = 0.519). Five-year overall survival estimate was 90.8% (95% CI 85.9–95.6) in NSRH and 84.1% (95% CI 8.0–88.3) in RH (P = 0.192). Rates of postoperative serious complications were 9.7% and 19.6% for NSRH and RH, respectively (P = 0.004). Positive pelvic lymph node and vagina status were significant (P < 0.01) independent predictors by multivariable analyses.

Conclusions

The oncologic results were comparable between NSRH and conventional class III RH in the context of two multimodal treatments. Bladder function and postoperative complications rate are improved by nerve-sparing technique. The nerve-sparing technique should be considered in all CC patients addressed to surgery because it improves functional outcome and preserves radicality without compromising overall survival.
Literatur
1.
Zurück zum Zitat Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954. Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954.
2.
Zurück zum Zitat Kobayashi T. Abdominal radical hysterectomy with pelvic lymphadenectomy for cancer of the cervix. Tokyo: Nanzando; 1961. p. 178–87. Kobayashi T. Abdominal radical hysterectomy with pelvic lymphadenectomy for cancer of the cervix. Tokyo: Nanzando; 1961. p. 178–87.
3.
Zurück zum Zitat Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111(2 Suppl):S33–41.PubMedCrossRef Fujii S. Anatomic identification of nerve-sparing radical hysterectomy: a step-by-step procedure. Gynecol Oncol. 2008;111(2 Suppl):S33–41.PubMedCrossRef
4.
Zurück zum Zitat Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol. 1991;164:7–14.PubMed Yabuki Y, Asamoto A, Hoshiba T, et al. Dissection of the cardinal ligament in radical hysterectomy for cervical cancer with emphasis on the lateral ligament. Am J Obstet Gynecol. 1991;164:7–14.PubMed
5.
Zurück zum Zitat Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998;178:971–6.PubMedCrossRef Hockel M, Konerding MA, Heussel CP. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol. 1998;178:971–6.PubMedCrossRef
6.
Zurück zum Zitat Possover M, Stober S, Plaul K, et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.PubMedCrossRef Possover M, Stober S, Plaul K, et al. Identification and preservation of the motoric innervation of the bladder in radical hysterectomy type III. Gynecol Oncol. 2000;79:154–7.PubMedCrossRef
7.
Zurück zum Zitat Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11:180–6.PubMedCrossRef Trimbos JB, Maas CP, Deruiter MC, et al. A nerve-sparing radical hysterectomy: guidelines and feasibility in Western patients. Int J Gynecol Cancer. 2001;11:180–6.PubMedCrossRef
8.
Zurück zum Zitat Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004;93:307–14.PubMedCrossRef Raspagliesi F, Ditto A, Fontanelli R, et al. Nerve-sparing radical hysterectomy: a surgical technique for preserving the autonomic hypogastric nerve. Gynecol Oncol. 2004;93:307–14.PubMedCrossRef
9.
Zurück zum Zitat Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953–7.PubMedCrossRef Ditto A, Martinelli F, Borreani C, et al. Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study. Int J Gynecol Cancer. 2009;19:953–7.PubMedCrossRef
10.
Zurück zum Zitat Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2–IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27:553–60.PubMed Papp Z, Csapo Z, Hupuczi P, et al. Nerve-sparing radical hysterectomy for stage IA2–IIB cervical cancer: 5-year survival of 501 consecutive cases. Eur J Gynaecol Oncol. 2006;27:553–60.PubMed
11.
Zurück zum Zitat Van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.PubMedCrossRef Van den Tillaart SA, Kenter GG, Peters AA, et al. Nerve-sparing radical hysterectomy: local recurrence rate, feasibility, and safety in cervical cancer patients stage IA to IIA. Int J Gynecol Cancer. 2009;19:39–45.PubMedCrossRef
12.
Zurück zum Zitat Skret-Magierło J, Naróg M, Kruczek A, et al. Radical hysterectomy during the transition period from traditional to nerve-sparing technique. Gynecol Oncol. 2010;116:502–5.PubMedCrossRef Skret-Magierło J, Naróg M, Kruczek A, et al. Radical hysterectomy during the transition period from traditional to nerve-sparing technique. Gynecol Oncol. 2010;116:502–5.PubMedCrossRef
13.
Zurück zum Zitat Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192–7.PubMedCrossRef Ditto A, Martinelli F, Hanozet F, et al. Class III NSRH: oncological outcome in 170 cervical cancer patients. Gynecol Oncol. 2010;119:192–7.PubMedCrossRef
14.
Zurück zum Zitat Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef Pecorelli S. FIGO Committee on Gynecologic Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.CrossRef
15.
Zurück zum Zitat Raspagliesi F, Ditto A, Kusamura S, et al. Nerve-sparing radical hysterectomy: a pilot study. Tumori. 2003;89:497–501.PubMed Raspagliesi F, Ditto A, Kusamura S, et al. Nerve-sparing radical hysterectomy: a pilot study. Tumori. 2003;89:497–501.PubMed
16.
Zurück zum Zitat Raspagliesi F, Ditto A, Hanozet F, et al. Nerve sparing radical hysterectomy for the treatment of cervical cancer: new research on surgical techniques. In: Varaj HT, editor. Trends in cervical cancer research. Hauppauge, NY: Nova Science Publishers; 2007. p. 97–123. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve sparing radical hysterectomy for the treatment of cervical cancer: new research on surgical techniques. In: Varaj HT, editor. Trends in cervical cancer research. Hauppauge, NY: Nova Science Publishers; 2007. p. 97–123.
17.
18.
Zurück zum Zitat Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–54.CrossRef Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141–54.CrossRef
19.
Zurück zum Zitat Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.CrossRef
20.
Zurück zum Zitat Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192–211.PubMedCrossRef Brucker PS, Yost K, Cashy J, et al. General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof. 2005;28:192–211.PubMedCrossRef
21.
Zurück zum Zitat Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.PubMedCrossRef Landoni F, Maneo A, Cormio G, et al. Class II versus class III radical hysterectomy in stage IB–IIA cervical cancer: a prospective randomized study. Gynecol Oncol. 2001;80:3–12.PubMedCrossRef
22.
Zurück zum Zitat Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206–11.PubMedCrossRef Girardi F, Lichtenegger W, Tamussino K, et al. The importance of parametrial lymph nodes in the treatment of cervical cancer. Gynecol Oncol. 1989;34:206–11.PubMedCrossRef
23.
Zurück zum Zitat Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.PubMedCrossRef Benedetti-Panici P, Maneschi F, Scambia G, et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol. 1996;62:19–24.PubMedCrossRef
24.
Zurück zum Zitat Raspagliesi F, Ditto A, Hanozet F, et al. Nerve-sparing radical hysterectomy in cervical cancer evolution of concepts. Gynecol Oncol. 2007;107(1 Suppl 1):S119–21. Raspagliesi F, Ditto A, Hanozet F, et al. Nerve-sparing radical hysterectomy in cervical cancer evolution of concepts. Gynecol Oncol. 2007;107(1 Suppl 1):S119–21.
25.
Zurück zum Zitat Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.PubMedCrossRef Raspagliesi F, Ditto A, Fontanelli R, et al. Type II versus type III nerve-sparing radical hysterectomy: comparison of lower urinary tract dysfunctions. Gynecol Oncol. 2006;102:256–62.PubMedCrossRef
26.
Zurück zum Zitat Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.PubMedCrossRef Samlal RA, Van der Velden J, Van Eerden T, et al. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.PubMedCrossRef
27.
Zurück zum Zitat Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179–88.PubMedCrossRef Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol. 2002;20:179–88.PubMedCrossRef
28.
Zurück zum Zitat Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23:4137–45.PubMedCrossRef Buda A, Fossati R, Colombo N, et al. Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol. 2005;23:4137–45.PubMedCrossRef
29.
Zurück zum Zitat Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20:660–5.PubMedCrossRef Lissoni AA, Colombo N, Pellegrino A, et al. A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study. Ann Oncol. 2009;20:660–5.PubMedCrossRef
30.
Zurück zum Zitat Trimbos JB, Franchi M, Zanaboni F, et al. “State of the art” of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40:375–8.PubMedCrossRef Trimbos JB, Franchi M, Zanaboni F, et al. “State of the art” of radical hysterectomy; current practice in European oncology centres. Eur J Cancer. 2004;40:375–8.PubMedCrossRef
31.
Zurück zum Zitat Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303.PubMedCrossRef Querleu D, Morrow CP. Classification of radical hysterectomy. Lancet Oncol. 2008;9:297–303.PubMedCrossRef
Metadaten
Titel
Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study
verfasst von
Antonino Ditto, MD
Fabio Martinelli, MD
Flavia Mattana, ScD
Claudio Reato, MD
Eugenio Solima, MD
Marialuisa Carcangiu, MD
Edward Haeusler, MD
Luigi Mariani, MD
Francesco Raspagliesi, MD
Publikationsdatum
01.11.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 12/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1767-3

Weitere Artikel der Ausgabe 12/2011

Annals of Surgical Oncology 12/2011 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wie sieht der OP der Zukunft aus?

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Recycling im OP – möglich, aber teuer

02.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.